VIdeo Telehealth in ALzheimer's: NeuroPsychology (VITAL-NP)

University of Colorado Denver (CU Denver)

Status

Completed

Conditions

Suspected Typical Alzheimer's Disease (AD)

Suspected Atypical Alzheimer's Disease (AD)

Treatments

Behavioral: Face-to-face evaluation (FF)

Behavioral: TeleNP evaluation

Study type

Interventional

Funder types

Other

NIH

Identifiers

NCT05379023

R21AG072153 (U.S. NIH Grant/Contract)

21-5037

Details and patient eligibility

About

The overarching goal of this study is to a) assess the feasibility and preliminary validity of home-based delivery of TeleNP to patients with suspected Alzheimer's Disease (AD), referred for cognitive assessments in a Neurology Clinic; and b) elucidate whether TeleNP is equivalent to face-to-face evaluation (FF) for diagnostic adjudication of atypical versus typical AD.

Enrollment

66 patients

Sex

All

Ages

60 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Individuals age 60 to 90 years who are undergoing evaluation for possible AD and whose severity ranges from MCI to mild dementia.
Individuals must carry a diagnosis of either suspected typical AD or atypical AD, based on the referring neurologist's diagnosis.

Exclusion criteria

Individuals with moderate to severe levels of dementia and individuals with active delirium (per neurologist's determination).
Individuals who are legally blind or deaf, due to the auditory and visual components of the study.
Individuals with a brain tumor and individuals who have a confirmed nonAD neurological diagnosis (e.g, Multiple Sclerosis; FTD).
Individuals who are being evaluated outside of the UCH Memory Disorders Clinic.
Individuals who report active (i.e., within the last 6 months) substance use of illicit drugs such as cocaine or methamphetamines, or who carry a diagnosis of a major psychiatric disorder (e.g., schizophrenia; bipolar disorder).